133 related articles for article (PubMed ID: 38146598)
1. Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: A cross-sectional and prospective study of 368,634 UK Biobank participants.
Wang J; Zeng L; Hong C; Cui H; Wang W; Zhu H; Li Q; Li Y; Li R; He J; Zhu H; Liu L; Xiao L
Clin Endocrinol (Oxf); 2024 Feb; 100(2):116-123. PubMed ID: 38146598
[TBL] [Abstract][Full Text] [Related]
2. Cross-Sectional and Longitudinal Associations of Creatinine-to-Cystatin C Ratio with Sarcopenia Parameters in Older Adults.
Kitago M; Seino S; Shinkai S; Nofuji Y; Yokoyama Y; Toshiki H; Abe T; Taniguchi Y; Amano H; Murayama H; Kitamura A; Akishita M; Fujiwara Y
J Nutr Health Aging; 2023; 27(11):946-952. PubMed ID: 37997714
[TBL] [Abstract][Full Text] [Related]
3. Associations between types and sources of dietary carbohydrates and liver fat: a UK Biobank study.
Orliacq J; Pérez-Cornago A; Parry SA; Kelly RK; Koutoukidis DA; Carter JL
BMC Med; 2023 Nov; 21(1):444. PubMed ID: 37968623
[TBL] [Abstract][Full Text] [Related]
4. Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer.
Tang T; Xie L; Hu S; Tan L; Lei X; Luo X; Yang L; Yang M
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1800-1810. PubMed ID: 35297568
[TBL] [Abstract][Full Text] [Related]
5. Trends in Oxidative Balance Score and Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in the United States: National Health and Nutrition Examination Survey 2001 to 2018.
Tan Z; Wu Y; Meng Y; Liu C; Deng B; Zhen J; Dong W
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068789
[TBL] [Abstract][Full Text] [Related]
6. Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.
Song Z; Miao X; Xie X; Tang G; Deng J; Hu M; Liu S; Leng S
Lipids Health Dis; 2024 May; 23(1):141. PubMed ID: 38760825
[TBL] [Abstract][Full Text] [Related]
7. Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.
Gao J; Li Y; Zhang Y; Zhan X; Tian X; Li J; Wang R; He Y; Wang A; Wu S
J Am Heart Assoc; 2024 Mar; 13(5):e032604. PubMed ID: 38390843
[TBL] [Abstract][Full Text] [Related]
8. Fatty Liver Index (FLI) is the best score to predict MASLD with 50% lower cut-off value in women than in men.
Crudele L; De Matteis C; Novielli F; Di Buduo E; Petruzzelli S; De Giorgi A; Antonica G; Berardi E; Moschetta A
Biol Sex Differ; 2024 May; 15(1):43. PubMed ID: 38760802
[TBL] [Abstract][Full Text] [Related]
9. Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up.
Choe HJ; Moon JH; Kim W; Koo BK; Cho NH
Metabolism; 2024 Apr; 153():155800. PubMed ID: 38266957
[TBL] [Abstract][Full Text] [Related]
10. Association of MAFLD and MASLD with all-cause and cause-specific dementia: a prospective cohort study.
Bao X; Kang L; Yin S; Engström G; Wang L; Xu W; Xu B; Zhang X; Zhang X
Alzheimers Res Ther; 2024 Jun; 16(1):136. PubMed ID: 38926784
[TBL] [Abstract][Full Text] [Related]
11. Muscle-origin creatinine-cystatin C ratio is an osteoporosis marker in individuals with normal renal function: evidence from observational and Mendelian randomization analysis.
He P; Yang YQ; Wang H; Zhang YQ; Gu YN; Hong CC; Bo L; Deng FY; Lei SF
Front Endocrinol (Lausanne); 2024; 15():1325320. PubMed ID: 38836225
[TBL] [Abstract][Full Text] [Related]
12. Association of serum creatinine to cystatin C to waist circumference ratios and hypertension: evidence from China health and retirement longitudinal study.
Yang Y; Sun Q; Ma S; Li X; Lang X; Zhang Q
Front Endocrinol (Lausanne); 2024; 15():1375232. PubMed ID: 38752178
[TBL] [Abstract][Full Text] [Related]
13. MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus.
Mantovani A; Morieri ML; Aldigeri R; Palmisano L; Masulli M; Bonomo K; Baroni MG; Cossu E; Cimini FA; Cavallo G; Buzzetti R; Mignogna C; Leonetti F; Bacci S; Trevisan R; Pollis RM; Cas AD; de Kreutzenberg SV; Targher G
Diabetes Metab; 2024 Jan; 50(1):101497. PubMed ID: 37992857
[TBL] [Abstract][Full Text] [Related]
14. Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study.
Israelsen M; Torp N; Johansen S; Hansen CD; Hansen ED; Thorhauge K; Hansen JK; Villesen I; Bech K; Wernberg C; Andersen P; Lindvig KP; Tsochatzis EA; Thiele M; Rinella ME; Krag A;
Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):218-228. PubMed ID: 38218202
[TBL] [Abstract][Full Text] [Related]
15. Exploring the landscape of steatotic liver disease in the general US population.
Ciardullo S; Carbone M; Invernizzi P; Perseghin G
Liver Int; 2023 Nov; 43(11):2425-2433. PubMed ID: 37592856
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of metabolic dysfunction-associated steatotic liver disease in south Central Uganda: A cross-sectional survey.
Enriquez R; Homsi M; Ssekubugu R; Nabukalu D; Zeebari Z; Marrone G; Gigante B; Chang LW; Reynolds SJ; Nalugoda F; Ekström AM; Hagström H; Nordenstedt H
Aliment Pharmacol Ther; 2024 May; 59(9):1111-1121. PubMed ID: 38459720
[TBL] [Abstract][Full Text] [Related]
17. The creatinine-to-cystatin C ratio (a surrogate marker of muscle mass) as a predictor of lung function decline in older adults: A nationwide longitudinal study in China.
Wang K; Jia S; Zhao W; Ge M; Dong B
Respir Med; 2023 May; 211():107197. PubMed ID: 36889519
[TBL] [Abstract][Full Text] [Related]
18. Association between muscle mass evaluated by computed tomography and the serum creatinine-cystatin C ratio in children with cancer: A cross-sectional study.
Kishimoto K; Hasegawa D; Uemura S; Nakamura S; Kozaki A; Saito A; Ishida T; Mori T; Kosaka Y
Nutrition; 2022; 99-100():111679. PubMed ID: 35533540
[TBL] [Abstract][Full Text] [Related]
19. The association of metabolic dysfunction-associated steatotic liver disease (MASLD) with the risk of myocardial infarction: a systematic review and meta-analysis.
Lv Q; Zhao H
Ann Med; 2024 Dec; 56(1):2306192. PubMed ID: 38253023
[No Abstract] [Full Text] [Related]
20. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease/Non-alcoholic Fatty Liver Disease With Type 2 Diabetes Mellitus: A Case-Control Study in a Tertiary Care Hospital in Pakistan.
Zahoor F; Saeed NU; Javed S; Sadiq HZ; Mand Khan F; Haider M; Shafqat MN; Maqbool A; Chaudhry A
Cureus; 2023 Oct; 15(10):e47240. PubMed ID: 38021965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
